WB and RT-qPCR assays of GPX4 generated results consistent with those of IF (Fig. 2c–e), whereas the expression trend of ACSL4 was opposite to that of GPX4, with lowest expression in the Sham group and highest in the CKD + CDDP group (Fig. 2d, f). Here, ACSL4 is linked to chronic kidney disease.